Positron Corporation

Positron Corporation
Public
Traded as OTC Pink: POSC
Industry Nuclear Medicine
Founded (1983 (1983))
Headquarters Westmont, Illinois, U.S.A
Products Nuclear medical imaging devices
Subsidiaries Positron Isotopes Corporation
Manhattan Isotope Technology
Website www.positron.com
www.posirx.com

Positron Corporation is an American nuclear medicine healthcare company specializing in cardiac Positron Emission Tomography (PET) imaging.[1][2] Positron operates in a variety of business areas combining cardiac PET imaging technology, radiopharmaceuticals and radioisotopes.[3] Positron is headquartered in Westmont, Illinois and holds three facilities: a radioisotope manufacturing facility in Lubbock, Texas, a clinical and technical cardiovascular PET training institute in Niagara Falls, New York and an automation manufacturing facility in Fishers, Indiana.[4][5]

The company's products and services enable healthcare providers to diagnose cardiac disease and improve patient outcomes.[4][6] Positron Corporation is a public company and traded on the Financial Industry Regulatory Authority, Inc.'s OTC Bulletin Board under the ticker symbol POSC.[5][7]

History

Positron was originally founded in 1983 as a research and development company.[8][9] The company expanded from a medical imaging device manufacturer to a nuclear healthcare company integrating the key components of the cardiac PET supply chain.[8] Positron's strategy focuses on stabilizing and securing the Sr-82 supply chain.[10]

In January 2012, Positron acquired Manhattan Isotope Technology.[9] This subsidiary focuses on increasing Sr-82 supply by processing proton irradiated target material, recycling Sr-82 from spent generators, and through its pursuit of procuring a 70 MeV cyclotron.[4][5][11]

Company development

After its founding in 1983, Positron debuted a new time-of-flight tomograph called the POSICAM.[12] Posicam used barium fluoride for the scintillation detector and was primarily used by researchers interested in cardiac imaging.[12] In 1985, the FDA approved the POSICAM system for marketing and the following year, Positron began commercial operations.[10] The FDA later gave approval to Positron to begin marketing its HZ PET imaging system in 1991.[10] Positron received patents for aspects of its HZ and HZL POSICAM systems in 1993 along with FDA approval to market HZL.[13]

In 2005, Positron entered into a joint venture contract with Neusoft Medical Systems Co., Inc. of Shenyang, China for a jointly owned company to pursue the manufacturing of PET imaging equipment called Neusoft Positron Medical Systems Co. Ltd.[3][13] The following year, Positron acquired a manufacturer/developer of nuclear imaging devices called IS2 Medical Systems, Inc. based in Ontario, Canada.[14] Positron acquired DoseShield Corporation, a developer and manufacturer of automated radiopharmaceutical technology/systems in 2008.[15] In 2009, Positron and its partner Neusoft Medical Systems received FDA approval to sell and distribute their Attrius PET system.[16][17]

Positron acquired Manhattan Isotope Technology (MIT), a processor and manufacturer of radioisotopes based in Lubbock, TX, in 2012.[4][5][18] In 2013, Positron entered into a supply agreement with iThemba Labs for radioisotopes,[19] and later the same year, Positron entered into a licensing agreement for radiostrontium production technology with INR.[20]

Attrius

The Attrius is Positron's main cardiac PET system that the company provides in nuclear medicine that was launched in 2010.[3] The system uses software to monitor coronary artery overlay display and open architecture for new protocol development and customization and motion correction.[21][22] Other products include PosiRx, a system that simplifies and controls the procedures associated with the preparation and delivery of radiopharmaceuticals used in molecular imaging and PosiStar, Positron's customer care plan for Attrius.[5][23]

70 MeV Cyclotron Project

In April 2013, Positron's subsidiary, Positron Isotopes Corporation, began planning to build and operate the world’s first, high-energy/high-current, commercial 70 MeV cyclotron.[4][5] The cyclotron project enables Positron to be the only entity in the United States, other than the U.S. Department of Energy to supply certain isotopes critical to cardiac PET imaging.[4][5]

The company produces active pharmaceutical ingredient (API) grade Sr-82 at its Lubbock, Texas, facility from strontium received from foreign irradiated source suppliers.[4][5] Positron supplements strontium resources through supply agreements with all domestic and foreign irradiated source suppliers, requesting increases in production schedules from third party suppliers, and by recycling expired generators.[9]

Awards

See also

References

  1. ↑ "Positron Corp". Morning Star. Retrieved 16 June 2014.
  2. ↑ "Positron Corp. touts regulatory wins in U.S., U.K.". Mass Device. 22 August 2012. Retrieved 16 June 2014.
  3. 1 2 3 "Positron Corp - Initiating Coverage at Hold". Zacks. 9 September 2011. Retrieved 16 June 2014.
  4. 1 2 3 4 5 6 7 "Positron Corp. (POSC) Positioned To Capitalize On Burgeoning PET Imaging Market". Seeking Alpha. 9 April 2013. Retrieved 16 June 2014.
  5. 1 2 3 4 5 6 7 8 9 Nadia Ibanez. "Positron Brings Innovation and Efficiency to Nuclear Medicine". Business Review USA. Retrieved 16 June 2014.
  6. ↑ Patrick G. Rooney (19 March 2012). "Positron Corporation". The Wall Street Transcript. Retrieved 16 June 2014.
  7. ↑ Colorado Stark (24 March 2011). "Positron Corporation (OTC:POSC) Still Attracting Attention". Trader Planet. Retrieved 16 June 2014.
  8. 1 2 "Company". Retrieved 16 June 2014.
  9. 1 2 3 "Form 10-K". U.S. Securities and Exchange Commission. 2012. Retrieved 16 June 2014.
  10. 1 2 3 "Form 10-KSB". U.S. Securities and Exchange Commission. 2006. Retrieved 16 June 2014.
  11. ↑ "Why PET will beat SPECT…". p. 22.
  12. 1 2 "The History PET Ronald Nutt, PhD" (PDF). ABT Molecular Imaging, Inc. Retrieved 16 June 2014.
  13. 1 2 "Form 10-KSB". U.S. Securities and Exchange Commission. 2006. Retrieved 16 June 2014.
  14. ↑ "Positron buys gamma camera firm IS2". Aunt Minnie. 6 June 2006. Retrieved 16 June 2014.
  15. ↑ "Positron acquires Dose Shield, forms new subsidiary". Houston Business Journal. 12 June 2008. Retrieved 16 June 2014.
  16. ↑ "Positron’s Attrius Scanner Product Line Gets FDA Approval". FDA News. Retrieved 16 June 2014.
  17. ↑ Dan Harvey (May 2012). "Cardiology Focus". Radiology Today Magazine. Retrieved 16 June 2014.
  18. ↑ Justine Varieur Cadet (17 January 2012). "Positron buys Manhattan Isotope for $3.5M". Molecular Imaging. Retrieved 16 June 2014.
  19. ↑ "Positron, iThemba LABS Enter Into Radioisotope Supply Agreement". Imaging Technology News. 9 August 2013. Retrieved 16 June 2014.
  20. ↑ "Positron signs deal with Russian academy". Aunt Minnie. 1 October 2013. Retrieved 16 June 2014.
  21. ↑ "Form 10-K". U.S. Securities and Exchange Commission. 2012. Retrieved 16 June 2014.
  22. ↑ Lisa Fratt (24 March 2011). "Inside the Transition to Flow-Based Patient Care". Cardiovascular Business. Retrieved 16 June 2014.
  23. ↑ Gene Ostrovsky (18 March 2011). "PosiRx Automated Radiopharmaceutical System Unveiled". medGadget. Retrieved 16 June 2014.
  24. ↑ "FLC National Awards" (PDF). Federal Technologies and Industry. 2012. Retrieved 16 June 2014.

Further reading

This article is issued from Wikipedia - version of the Monday, September 22, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.